Showing results (951-960 of 1,000) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|December 15, 2007
Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulatorsShephali Trivedi, Kim Dekermendjian, Ronald Julien, et al.
Assay and Drug Development Technologies|February 20, 2014
High-throughput high-content imaging assays for identification and characterization of selective AXL pathway inhibitorsHuaping Tang, Jing Yang, Ding Ren Shen, et al.
Assay and Drug Development Technologies|March 23, 2019
Technology for Discovery of Antifibrotic Drugs: Phenotypic Screening for LARP6 Inhibitors Using Inverted Yeast Three Hybrid SystemLela Stefanovic, Branko Stefanovic
Assay and Drug Development Technologies|July 18, 2019
High-Content Screening Identifies New Inhibitors of Connexin 43 Gap JunctionsChristèle Picoli, Emmanuelle Soleilhac, Agnès Journet, et al.
Assay and Drug Development Technologies|January 22, 2008
An optimized lentivirus-mediated RNAi screen reveals kinase modulators of kinesin-5 inhibitor sensitivityRichard A Klinghoffer, Brian Roberts, James Annis, et al.
Assay and Drug Development Technologies|March 1, 2021
Dual Drug Loaded Bilayer Hydrogel Coated with Citric Acid for the Treatment of Dry Mouth SyndromeRamya Devi Durai, Jaya Nallakkannu, Kalaimagal Rajaraman, et al.
Assay and Drug Development Technologies|November 12, 2021
Activities of Nanoparticles Against Fluconazole-Resistant Candida parapsilosis in Clinical IsolatesEnsieh Lotfali, Reza Ghasemi, Azam Fattahi, et al.
Assay and Drug Development Technologies|November 2, 2012
Metabolically functional hepatocyte-like cells from human umbilical cord lining epithelial cellsHan Hui Cheong, Jeyakumar Masilamani, Chun Yong Eric Chan, et al.
Assay and Drug Development Technologies|January 22, 2014
A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysisO Joseph Trask, Amanda Moore, Edward L LeCluyse
Pageof 100